Pretreatment With Norethindrone Acetate Prior to Levonorgestrel IUS Insertion for Heavy Menstrual Bleeding
Status:
Unknown status
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
Problematic uterine bleeding after the insertion of the LNG IUS is a well documented side
effect. The levonorgestrel intrauterine system (LNG IUS) was approved for treatment of heavy
menstrual bleeding (HMB) by the FDA in October 2009. To reduce the incidence and severity of
post-insertional uterine bleeding, pretreatment with norethindrone acetate may effectively
slough the endometrium prior to insertion of the LNG IUS.